What type of study is this?

September 10, 2025

Electrocardiographic and biochemical profile of acute coronary syndrome in hospitalized COVID-19 patients

Key Points

Among hospitalized COVID-19 patients, 26% experienced ECG-confirmed acute coronary syndrome.
Significantly high rates of inflammatory and cardiac biomarkers were found in older patients and those with diabetes.
Notably, STEMI was linked to age over 60, indicating an increased risk among older adults.
Early identification of cardiac issues related to COVID-19 is crucial for improving patient outcomes.

Abstract

COVID-19 has been associated with the occurrence of acute coronary syndromes (ACS) and the medical and scientific communities consider the virus to put acute coronary syndromes (ACS) at risk because of its inflammatory and thrombotic effects. In a cross-sectional study of 100 hospitalized patients with COVID-19, 26 percent had ECG-confirmed ACS (16 percent STEMI/10 percent NSTEMI). The highest rates of elevated inflammatory and cardiac biomarkers occurred among older people, as well as diabetic and hypertensive patients. STEMI was substantially correlated to age >60 and increased fatality. It has become vital to detect cardiac involvement of COVID-19 at an early stage to diminish negative outcomes.

Demander à l'IA

Bookmark